Alicja Sznarkowska

643 total citations
18 papers, 433 citations indexed

About

Alicja Sznarkowska is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Alicja Sznarkowska has authored 18 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Alicja Sznarkowska's work include Genomics, phytochemicals, and oxidative stress (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Alicja Sznarkowska is often cited by papers focused on Genomics, phytochemicals, and oxidative stress (4 papers), Liver Disease Diagnosis and Treatment (4 papers) and Hepatitis B Virus Studies (4 papers). Alicja Sznarkowska collaborates with scholars based in Poland, France and Sweden. Alicja Sznarkowska's co-authors include Anna Kostecka, Krzysztof Piotr Bielawski, Joanna Zawacka‐Pankau, Anna Kawiak, Elisabeth Hedström, Robert Olszewski, Robin Fåhræus, Ted R. Hupp, Monikaben Padariya and Alberto Inga and has published in prestigious journals such as Scientific Reports, FEBS Letters and Cell Death and Disease.

In The Last Decade

Alicja Sznarkowska

17 papers receiving 428 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alicja Sznarkowska Poland 10 210 115 50 47 46 18 433
Saba Hajazimian Iran 15 217 1.0× 99 0.9× 87 1.7× 64 1.4× 32 0.7× 27 489
Nefertiti El-Nikhely Egypt 13 233 1.1× 127 1.1× 72 1.4× 44 0.9× 23 0.5× 32 487
Aar Rafi Mahmud Bangladesh 4 230 1.1× 142 1.2× 85 1.7× 54 1.1× 28 0.6× 6 508
Aline Beckenkamp Brazil 13 170 0.8× 108 0.9× 36 0.7× 30 0.6× 39 0.8× 20 435
Anas Saadeddin Spain 13 379 1.8× 173 1.5× 67 1.3× 35 0.7× 44 1.0× 19 653
Muhammad Arshad Pakistan 8 201 1.0× 90 0.8× 42 0.8× 26 0.6× 63 1.4× 36 507
Małgorzata Kajstura United States 4 226 1.1× 79 0.7× 68 1.4× 29 0.6× 28 0.6× 7 379
Noureldien H. E. Darwish United States 14 246 1.2× 109 0.9× 59 1.2× 75 1.6× 33 0.7× 36 621
Fangyuan Shao China 14 319 1.5× 131 1.1× 87 1.7× 62 1.3× 36 0.8× 27 581
Lixian Wu China 16 350 1.7× 141 1.2× 66 1.3× 49 1.0× 42 0.9× 42 619

Countries citing papers authored by Alicja Sznarkowska

Since Specialization
Citations

This map shows the geographic impact of Alicja Sznarkowska's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alicja Sznarkowska with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alicja Sznarkowska more than expected).

Fields of papers citing papers by Alicja Sznarkowska

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alicja Sznarkowska. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alicja Sznarkowska. The network helps show where Alicja Sznarkowska may publish in the future.

Co-authorship network of co-authors of Alicja Sznarkowska

This figure shows the co-authorship network connecting the top 25 collaborators of Alicja Sznarkowska. A scholar is included among the top collaborators of Alicja Sznarkowska based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alicja Sznarkowska. Alicja Sznarkowska is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Piróg, Artur, Zuzanna Urban‐Wójciuk, Monikaben Padariya, et al.. (2025). Considerations for antibody-based detection of NRF2 in human cells. Redox Biology. 81. 103549–103549.
2.
Singh, A. Jonathan, Monikaben Padariya, Jakub Faktor, et al.. (2022). Identification of novel interferon responsive protein partners of human leukocyte antigen A (HLA-A) using cross-linking mass spectrometry (CLMS) approach. Scientific Reports. 12(1). 19422–19422. 3 indexed citations
3.
Padariya, Monikaben, et al.. (2021). Viruses, cancer and non-self recognition. Open Biology. 11(3). 200348–200348. 8 indexed citations
4.
Padariya, Monikaben, Alicja Sznarkowska, Sachin Kote, et al.. (2021). Functional Interfaces, Biological Pathways, and Regulations of Interferon-Related DNA Damage Resistance Signature (IRDS) Genes. Biomolecules. 11(5). 622–622. 29 indexed citations
5.
Rychłowski, Michał, et al.. (2021). Identification of a Stable, Non-Canonically Regulated Nrf2 Form in Lung Cancer Cells. Antioxidants. 10(5). 786–786. 9 indexed citations
6.
Rybicka, Magda, Alicja Sznarkowska, Piotr Stalke, et al.. (2020). Genetic variation in IL-10 influences the progression of hepatitis B infection. International Journal of Infectious Diseases. 96. 260–265. 16 indexed citations
7.
Rybicka, Magda, Anna Woziwodzka, Alicja Sznarkowska, et al.. (2020). Liver Cirrhosis in Chronic Hepatitis B Patients Is Associated with Genetic Variations in DNA Repair Pathway Genes. Cancers. 12(11). 3295–3295. 5 indexed citations
8.
Piszczek, Piotr, Aleksandra Radtke, Tomasz Jędrzejewski, et al.. (2020). Comprehensive Evaluation of the Biological Properties of Surface-Modified Titanium Alloy Implants. Journal of Clinical Medicine. 9(2). 342–342. 32 indexed citations
9.
Sznarkowska, Alicja, et al.. (2020). MHC Class I Regulation: The Origin Perspective. Cancers. 12(5). 1155–1155. 14 indexed citations
10.
Rybicka, Magda, et al.. (2019). Host genetic background affects the course of infection and treatment response in patients with chronic hepatitis B. Journal of Clinical Virology. 120. 1–5. 5 indexed citations
11.
Woziwodzka, Anna, et al.. (2019). TNF‐α polymorphisms affect persistence and progression of HBV infection. Molecular Genetics & Genomic Medicine. 7(10). e00935–e00935. 9 indexed citations
12.
Sznarkowska, Alicja, Anna Kostecka, Anna Kawiak, et al.. (2018). Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells. Cell Division. 13(1). 10–10. 12 indexed citations
13.
Sznarkowska, Alicja, et al.. (2016). Inhibition of cancer antioxidant defense by natural compounds. Oncotarget. 8(9). 15996–16016. 171 indexed citations
14.
Kostecka, Anna, Alicja Sznarkowska, Pilar Acedo, et al.. (2014). JNK–NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. Cell Death and Disease. 5(10). e1484–e1484. 29 indexed citations
15.
Sznarkowska, Alicja, Robert Olszewski, & Joanna Zawacka‐Pankau. (2010). [Pharmacological activation of tumor suppressor, wild-type p53 as a promising strategy to fight cancer].. PubMed. 64. 396–407. 19 indexed citations
16.
Zawacka‐Pankau, Joanna, Anna Kostecka, Alicja Sznarkowska, Elisabeth Hedström, & Anna Kawiak. (2010). p73 tumor suppressor protein: A close relative of p53 not only in structure but also in anti-cancer approach?. Cell Cycle. 9(4). 720–728. 56 indexed citations
17.
Sznarkowska, Alicja, et al.. (2010). Targeting of p53 and its homolog p73 by protoporphyrin IX. FEBS Letters. 585(1). 255–260. 15 indexed citations
18.
Zawacka‐Pankau, Joanna, Katarzyna Maleńczyk, & Alicja Sznarkowska. (2010). [The structure and cellular regulation of p73: their implication in anticancer therapy].. PubMed. 64. 78–86. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Saba Hajazimian Breakdown of academic impact, for papers by Nefertiti El-Nikhely Breakdown of academic impact, for papers by Aar Rafi Mahmud Breakdown of academic impact, for papers by Aline Beckenkamp Breakdown of academic impact, for papers by Anas Saadeddin Breakdown of academic impact, for papers by Muhammad Arshad Breakdown of academic impact, for papers by Małgorzata Kajstura Breakdown of academic impact, for papers by Noureldien H. E. Darwish Breakdown of academic impact, for papers by Fangyuan Shao Breakdown of academic impact, for papers by Lixian Wu
Rankless by CCL
2026